![]() |
|
|
Molecular Pharmacology, Vol 4, 402-404, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics
1 Laboratories of Pharmacology, Children’s Cancer Research Foundation, and
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Phosphorylation of cytosine arabinoside, a requisite for drug action, was catalyzed by deoxycytidine kinase. This reaction was strongly inhibited by deoxycytidine and by deoxycytidine nucleotides. An examination of kinetic data indicates the Ki for deoxycytidine was 40-fold smaller than the Km for cytosine arabinoside. This difference apparently explains one site of the reversal of cytosine arabinoside toxicity by deoxycytidine.
Note:
This work was supported, in part, by contract
PH 43-66-541 from the Cancer Chemotherapy
National Service Center, National Cancer
Institute, National Institutes of Health. The
author wishes to express his appreciation to Miss
Marjorie Myers for assistance in this study.